水晶光電(002273.SZ):第四期員工持股計劃第一批股票出售完畢
格隆匯 7 月 27日丨水晶光電(002273.SZ)公佈,第四期員工持股計劃第一批股票合計553.1532萬股於2020年7月22日至7月24日通過二級市場集中競價方式出售,佔公司總股本的比例為0.45%,成交價格區間:15.01元/股—16.93元/股。
第一批已解鎖股票尚有23股零股受交易規則限制未能賣出,將計入本員工持股計劃第二批股票解鎖後一併處置。至此,本員工持股第一批股票已出售完畢,後續將進行相應財產清算和分配工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.